Harris is Professor at King’s College London and founder of multiple successful spin-outs, he specializes in process engineering and works on integrating intelligent automation with engineering to accelerate the discovery and large-scale manufacture of genetic medicines. he is Expert in RNA Manufacturing and has secured multi-million dollar funding to develop "Biofoundry-in-a-Box(TM)" technologies and autonomous RNA manufacturing platforms, which are currently deployed in GMP environments for clinical programs. An award-winning scientist recognized by the Royal Academy of Engineering for services against the SARS-CoV-2 pandemic, he has authored over 80 papers and holds 6 patent families in intelligent bioprocess and chemical reactor technology. With nearly 30 years of cross-sector experience spanning chemicals, semiconductors, and genetic medicines, he is expert in leading global consortia that require integration and coordination. His has strong interests in creating self-optimizing equipment for distributed healthcare manufacturing, with particualr focus on genetic medicines.